Eastern Mediterranean (WHO region) vs Hong Kong, China: Treatment success rate: XDR-TB cases

Eastern Mediterranean (WHO region)
74
in 2022
Hong Kong, China
100
in 2022
Eastern Mediterranean (WHO region) rank
1st
Hong Kong, China rank
1st

Treatment success rate: XDR-TB cases over time

  • Eastern Mediterranean (WHO region)
  • Hong Kong, China
020406080100200820152022

How they compare

Hong Kong, China currently reports 100 against 74 in Eastern Mediterranean (WHO region), a difference of 26.

That makes Hong Kong, China's figure about 1.4 times Eastern Mediterranean (WHO region)'s.

The two have swapped places 4 times across 13 shared years of data; in 2008 it was Hong Kong, China ahead.

Eastern Mediterranean (WHO region) ranks 1st and Hong Kong, China ranks 1st of 11 groups.

Hong Kong, China has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Eastern Mediterranean (WHO region) Hong Kong, China Difference Ahead
2000s 0 50 50 Hong Kong, China
2010s 40.89 79.67 38.78 Hong Kong, China
2020s 72 89 17 Hong Kong, China

Averages of every year both report within each decade.

Frequently asked questions

Which has higher treatment success rate: xdr-tb cases, Eastern Mediterranean (WHO region) or Hong Kong, China?
Hong Kong, China, at 100 against 74 in Eastern Mediterranean (WHO region) as of 2022.
What is the difference in treatment success rate: xdr-tb cases between Eastern Mediterranean (WHO region) and Hong Kong, China?
26, with Hong Kong, China ahead.
How many years of comparable data are there for Eastern Mediterranean (WHO region) and Hong Kong, China?
13 years are reported by both, from 2008 to 2022.
How do Eastern Mediterranean (WHO region) and Hong Kong, China rank globally for treatment success rate: xdr-tb cases?
Eastern Mediterranean (WHO region) ranks 1st and Hong Kong, China ranks 1st of 11 groups.
Where does this data come from?
World Health Organization, Global Health Observatory, published as Treatment success rate: XDR-TB cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Eastern Mediterranean (WHO region) vs Hong Kong, China: Treatment success rate: XDR-TB cases. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 16 September 2026, from https://health.statizoid.com/compare/treatment-success-rate-xdr-tb-cases/eastern-mediterranean-who-region/hong-kong-sar-china/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/treatment-success-rate-xdr-tb-cases/eastern-mediterranean-who-region/hong-kong-sar-china/">Eastern Mediterranean (WHO region) vs Hong Kong, China: Treatment success rate: XDR-TB cases</a> — Statizoid

About this data

Indicator
Treatment success rate: XDR-TB cases
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
93 places, 901 data points, 2008–2022
Last refreshed